{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:37:56Z","timestamp":1789627076127,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ccm.2017.04.014","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T18:45:50Z","timestamp":1496429150000},"page":"555-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emergence of the Molds Other than Aspergillus in Immunocompromised Patients"],"prefix":"10.1016","volume":"38","author":[{"given":"Sana","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/cid\/cir864","article-title":"Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives","volume":"54","author":"Kwon-Chung","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Pt 5","key":"10.1016\/j.ccm.2017.04.014_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mycres.2007.03.004","article-title":"A\u00a0higher-level phylogenetic classification of the Fungi","volume":"111","author":"Hibbett","year":"2007","journal-title":"Mycol Res"},{"issue":"12","key":"10.1016\/j.ccm.2017.04.014_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycosis","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/mmy\/myu086","article-title":"A\u00a0prospective study of mucormycosis in north India: experience from a tertiary care hospital","volume":"53","author":"Bala","year":"2015","journal-title":"Med Mycol"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2017.04.014_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: unique features","volume":"57","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib8","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A\u00a0global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib10","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2014.08.006","article-title":"A\u00a0registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation","volume":"21","author":"Fox","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib13","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib15","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3201\/eid2003.131230","article-title":"Invasive fungal infections after natural disasters","volume":"20","author":"Benedict","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib17","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4161\/viru.2.4.17074","article-title":"Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection","volume":"2","author":"Lewis","year":"2011","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin concentrations below the minimum inhibitory concentration attenuate the virulence of Rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/lt.21587","article-title":"Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens","volume":"14","author":"Singh","year":"2008","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib22","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1086\/315919","article-title":"Effect of transfusional iron overload on immune response","volume":"182","author":"Cunningham-Rundles","year":"2000","journal-title":"J\u00a0Infect Dis"},{"issue":"06","key":"10.1016\/j.ccm.2017.04.014_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1079\/BJN19940094","article-title":"The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse","volume":"72","author":"Omara","year":"1994","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(10)70316-9","article-title":"Mucormycosis: its contemporary face and management strategies","volume":"11","author":"Sun","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"10.1016\/j.ccm.2017.04.014_bib25","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2006.06.003","article-title":"Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management","volume":"20","author":"Kontoyiannis","year":"2006","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2017.04.014_bib31","first-page":"1629","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/7KU5XWURYM0151YN","article-title":"Increased culture recovery of Zygomycetes under physiologic temperature conditions","volume":"127","author":"Kontoyiannis","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.01640-16","article-title":"Identification of molds by MALDI-TOF mass spectrometry","volume":"55","author":"Sanguinetti","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib34","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib35","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/JCM.00902-10","article-title":"Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa","volume":"48","author":"Borras","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib36","doi-asserted-by":"crossref","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.ccm.2017.04.014_bib40","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib41","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib44","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2017.04.014_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/myc.12222","volume":"57","author":"Abidi","year":"2014","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"Ibrahim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1016\/j.ccm.2017.04.014_bib48","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2017.04.014_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1469-0691.2009.02986.x","article-title":"Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis","volume":"15","author":"Tragiannidis","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib51","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/AAC.00456-09","article-title":"Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice","volume":"53","author":"Rodriguez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.emc.2008.01.005","article-title":"Hyperbaric oxygen: applications in infectious disease","volume":"26","author":"Kaide","year":"2008","journal-title":"Emerg Med Clin North Am"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib53","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib54","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox\u2013AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5598\/imafungus.2011.02.02.06","article-title":"A\u00a0new dawn for the naming of fungi: impacts of decisions made in Melbourne in July 2011 on the future publication and regulation of fungal names","volume":"2","author":"Hawksworth","year":"2011","journal-title":"IMA Fungus"},{"issue":"12","key":"10.1016\/j.ccm.2017.04.014_bib56","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10096-013-1924-7","article-title":"Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment","volume":"32","author":"Guarro","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/383319","article-title":"Fusarium infection in hematopoietic stem cell transplant recipients","volume":"38","author":"Nucci","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.11510","article-title":"Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection","volume":"98","author":"Nucci","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib59","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/cid\/ciu947","article-title":"Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients","volume":"60","author":"Garnica","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2017.04.014_bib60","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1086\/324501","article-title":"Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections","volume":"33","author":"Anaissie","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1099\/00222615-48-4-363","article-title":"Experimental pathogenicity of four opportunist Fusarium species in a murine model","volume":"48","author":"Mayayo","year":"1999","journal-title":"J\u00a0Med Microbiol"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib62","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CMR.7.4.479","article-title":"Taxonomy, biology, and clinical aspects of Fusarium species","volume":"7","author":"Nelson","year":"1994","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib63","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/jac\/dkv198","article-title":"Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study","volume":"70","author":"Davoudi","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/342328","article-title":"Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management","volume":"35","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib65","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"A\u00a0significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib66","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archopht.123.5.702","article-title":"Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia","volume":"123","author":"Rezai","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10096-002-0812-3","article-title":"Comparison of aerobic standard medium with specific fungal medium for detecting fusarium spp in blood cultures","volume":"21","author":"Hennequin","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib68","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/JCM.38.9.3460-3462.2000","article-title":"Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient","volume":"38","author":"Guarro","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib69","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"5\u20136","key":"10.1016\/j.ccm.2017.04.014_bib70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1439-0507.1992.tb00830.x","article-title":"Fusarium infections. criteria for the identification of the responsible species","volume":"35","author":"Guarro","year":"1992","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib71","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1469-0691.2009.02758.x","article-title":"Use of mass spectrometry to identify clinical Fusarium isolates","volume":"15","author":"Marinach-Patrice","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.ccm.2017.04.014_bib72","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/JCM.37.11.3586-3589.1999","article-title":"Identification of fusarium species involved in human infections by 28S rRNA gene sequencing","volume":"37","author":"Hennequin","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ajcp\/109.1.45","article-title":"Morphologic criteria for the preliminary identification of fusarium, paecilomyces, and acremonium species by histopathology","volume":"109","author":"Liu","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib74","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2214\/AJR.07.3278","article-title":"Imaging of pulmonary fusariosis in patients with hematologic malignancies","volume":"190","author":"Marom","year":"2008","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib75","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib76","doi-asserted-by":"crossref","first-page":"e87784","DOI":"10.1371\/journal.pone.0087784","article-title":"Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing","volume":"9","author":"Nucci","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2017.04.014_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib78","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/jac\/dkr143","article-title":"Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi","volume":"66","author":"Guarro","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib79","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/AAC.00176-08","article-title":"In\u00a0vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum","volume":"52","author":"Azor","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib80","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jac\/dkp095","article-title":"High genetic diversity and poor in\u00a0vitro response to antifungals of clinical strains of Fusarium oxysporum","volume":"63","author":"Azor","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib81","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkn022","article-title":"Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods","volume":"61","author":"Alastruey-Izquierdo","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib82","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.00272-08","article-title":"Species distribution and in\u00a0vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from Northern Italy","volume":"52","author":"Tortorano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib83","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01618-06","article-title":"Universal in\u00a0vitro antifungal resistance of genetic clades of the Fusarium solani species complex","volume":"51","author":"Azor","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2017.04.014_bib84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1439-0507.2002.tb04771.x","article-title":"The first echinocandin: caspofungin","volume":"45","author":"Cornely","year":"2002","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/39.2.163","article-title":"In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains","volume":"39","author":"Pujol","year":"1997","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.ccm.2017.04.014_bib86","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1128\/JCM.37.12.3946-3951.1999","article-title":"Microdilution susceptibility testing of amphotericin b, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species","volume":"37","author":"Arikan","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Suppl 6","key":"10.1016\/j.ccm.2017.04.014_bib87","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1086\/429331","article-title":"Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex","volume":"40","author":"Perfect","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.04.014_bib88","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib89","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00286-10","article-title":"International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole","volume":"54","author":"Lortholary","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib90","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","article-title":"Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11046-010-9324-3","article-title":"Isavuconazole: a comprehensive review of spectrum of activity of a new triazole","volume":"170","author":"Thompson","year":"2010","journal-title":"Mycopathologia"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib92","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/JCM.41.10.4898-4900.2003","article-title":"Successful outcome of disseminated fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia","volume":"41","author":"Durand-Joly","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib93","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10156-013-0594-9","article-title":"Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review","volume":"19","author":"Inano","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijantimicag.2007.09.005","article-title":"In\u00a0vitro interactions of antifungal agents against clinical isolates of Fusarium spp","volume":"31","author":"Cordoba","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2003.09.003","article-title":"In\u00a0vitro interactions of licensed and novel antifungal drugs against Fusarium spp","volume":"48","author":"Ortoneda","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.funbio.2015.09.003","article-title":"The 'species complex' issue in clinically relevant fungi: a case study in Scedosporium apiospermum","volume":"120","author":"Chen","year":"2016","journal-title":"Fungal Biol"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13225-014-0295-4","article-title":"Proposed nomenclature for Pseudallescheria, Scedosporium and related genera","volume":"67","author":"Lackner","year":"2014","journal-title":"Fungal Diversity"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","author":"Cortez","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"9264","key":"10.1016\/j.ccm.2017.04.014_bib99","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(00)04423-8","article-title":"Airborne outbreak of nosocomial Scedosporium prolificans infection","volume":"357","author":"Guerrero","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13693780802524506","article-title":"Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases","volume":"47","author":"Rodriguez-Tudela","year":"2009","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","article-title":"Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome","volume":"40","author":"Husain","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Pt 1","key":"10.1016\/j.ccm.2017.04.014_bib102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj3150119","article-title":"A\u00a033 kDa serine proteinase from Scedosporium apiospermum","volume":"315","author":"Larcher","year":"1996","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13693780902738006","article-title":"Host immune response against Scedosporium species","volume":"47","author":"Roilides","year":"2009","journal-title":"Med Mycol"},{"issue":"32","key":"10.1016\/j.ccm.2017.04.014_bib104","doi-asserted-by":"crossref","first-page":"22614","DOI":"10.1074\/jbc.M511417200","article-title":"An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation","volume":"281","author":"Bittencourt","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2004.07.016","article-title":"Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp","volume":"31","author":"Winn","year":"2005","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib106","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1439-0507.2007.01388.x","article-title":"Scedosporium apiospermum infection after near-drowning","volume":"50","author":"Katragkou","year":"2007","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib107","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100960050011","article-title":"Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis","volume":"19","author":"Cimon","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-2712(18)30336-6","article-title":"New aspects of emerging fungal pathogens. A multifaceted challenge","volume":"15","author":"Schell","year":"1995","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib109","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JCM.01470-09","article-title":"Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media","volume":"48","author":"Blyth","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ccm.2017.04.014_bib110","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinids\/11.6.890","article-title":"Central nervous system infection caused by Pseudallescheria boydii: case report and review","volume":"11","author":"Berenguer","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib111","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JCM.01810-10","article-title":"Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis","volume":"49","author":"Harun","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib112","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13693780500474327","article-title":"Differences in beta-glucan levels in culture supernatants of a variety of fungi","volume":"44","author":"Odabasi","year":"2006","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib113","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib114","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In\u00a0vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00365540600786564","article-title":"Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine","volume":"39","author":"Bhat","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.ccm.2017.04.014_bib117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1439-0507.2003.00878.x","article-title":"Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery","volume":"46","author":"Gosbell","year":"2003","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib118","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2004.07.011","article-title":"Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis","volume":"50","author":"Ortoneda","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2017.04.014_bib119","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/clinids\/22.Supplement_2.S179","article-title":"Identification of dematiaceous fungi and their role in human disease","volume":"22","author":"Fothergill","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/tid.12197","article-title":"Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment","volume":"16","author":"Schieffelin","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2017.04.014_bib121","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/597400","article-title":"Phaeohyphomycosis in a tertiary care cancer center","volume":"48","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.04.014_bib122","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/mmy\/myv018","article-title":"Phaeohyphomycosis in transplant recipients: results from the transplant associated infection surveillance network (TRANSNET)","volume":"53","author":"McCarty","year":"2015","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.ccm.2017.04.014_bib123","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.69.3.1781-1794.2001","article-title":"Molecular cloning and characterization ofWdPKS1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella(Exophiala) dermatitidis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ccm.2017.04.014_bib124","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/IAI.67.1.94-101.1999","article-title":"Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils","volume":"67","author":"Schnitzler","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archotol.1991.01870140062007","article-title":"Culture-positive allergic fungal sinusitis","volume":"117","author":"Manning","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/514528","article-title":"Disseminated infection due to Bipolaris australiensis in a young immunocompetent man: case report and review","volume":"25","author":"Flanagan","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib127","first-page":"68","article-title":"Disseminated Bipolaris infection in an immunocompetent host: an atypical presentation","volume":"50","author":"Khan","year":"2000","journal-title":"J\u00a0Pak Med Assoc"},{"issue":"16","key":"10.1016\/j.ccm.2017.04.014_bib128","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1117018109","article-title":"Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi","volume":"109","author":"Schoch","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2017.04.014_bib129","first-page":"36","article-title":"Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi","volume":"15","author":"Brandt","year":"2003","journal-title":"J\u00a0Chemother"},{"issue":"7","key":"10.1016\/j.ccm.2017.04.014_bib130","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/JCM.00653-10","article-title":"Use of amplified fragment length polymorphism to identify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in\u00a0vitro antifungal susceptibility","volume":"48","author":"Badali","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.ccm.2017.04.014_bib131","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/AAC.01218-15","article-title":"In\u00a0vitro activities of eight antifungal drugs against a global collection of genotyped Exserohilum isolates","volume":"59","author":"Chowdhary","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ccm.2017.04.014_bib132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2017.04.014_bib133","first-page":"121","article-title":"In\u00a0vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature","volume":"20","author":"Espinel-Ingroff","year":"2003","journal-title":"Rev Iberoam Micol"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523117300497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523117300497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:53:45Z","timestamp":1759452825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523117300497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0272523117300497"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2017.04.014","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of the Molds Other than Aspergillus in Immunocompromised Patients","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2017.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}